Back to Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.

All insiders

5 insiders

InsiderRole% of sharesShares heldLast trade
Gould Robert JDirector0.60%454,864Feb 2, 2026
Musso Alan AChief Financial OfficerFeb 2, 2026
Oltmans Curtis GaleChief Legal OfficerFeb 2, 2026
Sapir AlexSee Remarks · DirectorFeb 2, 2026
Tourangeau GregPrincipal Accounting OfficerFeb 2, 2026
← PrevPage 1 of 1Next →